一项评价1.5%盐酸米诺环素泡沫剂局部给药治疗丘疹脓疱型玫瑰痤疮的多中心、随机、双盲、赋形剂对照的有效性和安全性的Ⅲ期临床研究
[Translation] A multicenter, randomized, double-blind, vehicle-controlled phase III clinical study evaluating the efficacy and safety of topical administration of 1.5% minocycline hydrochloride foam in the treatment of papulopustular rosacea
主要研究目的:评估每日一次局部外用,与赋形剂相比,治疗12周时, CU-10301治疗丘疹脓疱型玫瑰痤疮的有效性;
次要研究目的:评估每日一次局部外用,与赋形剂相比,治疗12周时,CU-10301治疗丘疹脓疱型玫瑰痤疮的安全性。
[Translation] MAIN STUDY OBJECTIVE: To evaluate the efficacy of CU-10301 in the treatment of papulopustular rosacea when applied topically once daily, compared with vehicle, at 12 weeks of treatment;
Secondary study objectives: To evaluate the safety of CU-10301 in the treatment of papulopustular rosacea when applied topically once daily, compared with vehicle, at 12 weeks of treatment.
一项评价盐酸米诺环素泡沫剂(4%)局部给药治疗中度至重度寻常痤疮的多中心、随机双盲、赋形剂对照的有效性和安全性的III期研究
[Translation] A multicenter, randomized, double-blind, vehicle-controlled phase III study evaluating the efficacy and safety of topical minocycline hydrochloride foam (4%) in the treatment of moderate to severe acne vulgaris
评估每天局部外用,治疗12周时,与赋形剂相比,FMX101 4%治疗寻常痤疮的疗效;
评估每天局部外用,治疗12周时,与赋形剂相比,FMX101 4%治疗寻常痤疮的安全性。
[Translation] To evaluate the efficacy of FMX101 4% in the treatment of acne vulgaris compared with vehicle at 12 weeks of daily topical use;
To evaluate the safety of FMX101 4% in the treatment of acne vulgaris compared with vehicle at 12 weeks of daily topical use.
100 Clinical Results associated with VYNE Pharmaceuticals, Inc.
0 Patents (Medical) associated with VYNE Pharmaceuticals, Inc.
100 Deals associated with VYNE Pharmaceuticals, Inc.
100 Translational Medicine associated with VYNE Pharmaceuticals, Inc.